Organ transplant device maker TransMedics files for an $86 million IPO

TransMedics, a medical device company that provides a system for organ transplants, filed on Friday with the SEC to raise up to $86 million in an initial public offering.

The Andover, MA-based company was founded in 1998 and booked $13 million in sales for the 12 months ended December 31, 2018. It plans to list on the Nasdaq under the symbol TMDX. TransMedics filed confidentially on October 19, 2018. Morgan Stanley and J.P. Morgan are the joint bookrunners on the deal. No pricing terms were disclosed.

Relevant Profile: TMDX

https://www.renaissancecapital.com/IPO-Center/News/62532/Organ-transplant-device-maker-TransMedics-files-for-an-$86-million-IPO